Article Details
Retrieved on: 2021-01-26 23:59:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Withdrawal of a CBD guidance document, while expected, highlights the CBD industry's frustrations with FDA inaction to regulate the market.
Article found on: www.naturalproductsinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here